A Novel Messenger RNA Signature as a Biomarker for Predicting Early Relapse in Non-Small Cell Lung Cancer

2018 ◽  
Author(s):  
Jing Li ◽  
Xiaoxia Liu ◽  
Wenqian Xu ◽  
Xin Wang
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Messenger Rna ◽  
Small Cell ◽  
Small Cell Lung ◽  
Early Relapse ◽  
Rna Signature

scholarly journals Association of PALB2 Messenger RNA Expression with Platinum-Docetaxel Efficacy in Advanced Non–Small Cell Lung Cancer

2019 ◽  
Vol 14 (2) ◽  
pp. 304-310 ◽  
Author(s):  
Niki Karachaliou ◽  
Jillian Wilhelmina Paulina Bracht ◽  
Manuel Fernandez Bruno ◽  
Ana Drozdowskyj ◽  
Ana Gimenez Capitan ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Messenger Rna ◽  
Small Cell ◽  
Rna Expression ◽  
Small Cell Lung

scholarly journals Ribonucleotide Reductase Messenger RNA Expression and Survival in Gemcitabine/Cisplatin-Treated Advanced Non-Small Cell Lung Cancer Patients

2004 ◽  
Vol 10 (4) ◽  
pp. 1318-1325 ◽  
Author(s):  
Rafael Rosell ◽  
Kathleen D. Danenberg ◽  
Vincente Alberola ◽  
Gerold Bepler ◽  
Jose Javier Sanchez ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Ribonucleotide Reductase ◽  
Messenger Rna ◽  
Small Cell ◽  
Rna Expression ◽  
Small Cell Lung ◽  
Lung Cancer Patients

scholarly journals Osteopontin But Not Osteonectin Messenger RNA Expression Is a Prognostic Marker in Curatively Resected Non-Small Cell Lung Cancer

2004 ◽  
Vol 10 (5) ◽  
pp. 1588-1596 ◽  
Author(s):  
Sylke Schneider ◽  
JiMin Yochim ◽  
Jan Brabender ◽  
Kazumi Uchida ◽  
Kathleen D. Danenberg ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Prognostic Marker ◽  
Cell Lung Cancer ◽  
Messenger Rna ◽  
Small Cell ◽  
Rna Expression ◽  
Small Cell Lung

scholarly journals A seven-long noncoding RNA signature predicts overall survival for patients with early stage non-small cell lung cancer

Aging ◽  
2018 ◽  
Vol 10 (9) ◽  
pp. 2356-2366 ◽  
Author(s):  
Ting Lin ◽  
Yunong Fu ◽  
Xing Zhang ◽  
Jingxian Gu ◽  
Xiaohua Ma ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Overall Survival ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Long Noncoding Rna ◽  
Noncoding Rna ◽  
Early Stage ◽  
Small Cell ◽  
Small Cell Lung ◽  
Rna Signature

scholarly journals O-021ASSOCIATION OF CIRCULATING TUMOUR CELLS WITH EARLY RELAPSE AND 18F-FDG PET UPTAKE IN RESECTED NON-SMALL CELL LUNG CANCER

2016 ◽  
Vol 23 (suppl 1) ◽  
pp. i6.4-i7
Author(s):  
Clara Isabel Bayarri-Lara ◽  
M.J. Serrano ◽  
M.J. Moyano ◽  
D. Miguel-Pérez ◽  
A. Rodriguez-Fernández ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Fdg Pet ◽  
Small Cell ◽  
Tumour Cells ◽  
Circulating Tumour Cells ◽  
Small Cell Lung ◽  
Early Relapse ◽  
18F Fdg

scholarly journals The Prognostic Effect of MAC30 Expression on Patients With Non–Small Cell Lung Cancer Receiving Adjuvant Chemotherapy

2016 ◽  
Vol 16 (5) ◽  
pp. 645-653 ◽  
Author(s):  
Hui Ding ◽  
Xianhua Gui ◽  
Xubo Lin ◽  
Ruhua Chen ◽  
Tieliang Ma ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Adjuvant Chemotherapy ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Messenger Rna ◽  
Disease Free Survival ◽  
Small Cell ◽  
Tumor Differentiation ◽  
Small Cell Lung ◽  
Free Survival

The purpose of this study was to examine the MAC30 expression in non–small cell lung cancer and to evaluate its prognostic value on therapeutic response in patients with non–small cell lung cancer receiving postoperative chemotherapy. Among a total of 218 retrospective Chinese patients with non–small cell lung cancer, 164 patients receiving adjuvant chemotherapy were enrolled in this study. Real-time polymerase chain reaction was performed to confirm the expression of MAC30 messenger RNA in 32 cases of non–small cell lung cancer tumors with the corresponding nontumor lung tissues. The MAC30 protein expression in all specimens was analyzed by immunohistochemical staining. Moreover, we assessed the correlation of MAC30 expression with clinicopathological features, therapeutic response, and survival of patients. Here, we observed the increased expression of MAC30 messenger RNA in patients with non–small cell lung cancer compared to those in control samples. The overexpression of MAC30 was strongly associated with poor tumor differentiation, high tumor–node–metastasis stage, and lymph node metastasis. In addition, we observed that patients with increased MAC30 expression showed gloomy overall survival and disease-free survival. A multivariate analysis explicated that higher MAC30 expression was a valuable independent prognostic factor of poorer tumor differentiation, shorter overall survival, and disease-free survival in patients receiving chemotherapy. MAC30 could be a useful biomarker of tumor differentiation and outcome of patients with non–small cell lung cancer. Overexpression of MAC30 predicts a worse tumor differentiated stage and prognosis in patients with non–small cell lung cancer receiving adjuvant chemotherapy.

Messenger-RNA Expression of Five Gemcitabine Sensitivity-related Genes Predicting Outcome in Advanced-stage Non-small Cell Lung Cancer

2020 ◽  
Vol 40 (2) ◽  
pp. 901-913
Author(s):  
GEORGIOS IOANNIDIS ◽  
CHARA PAPADAKI ◽  
ELENI LAGOUDAKI ◽  
MARIA TZARDI ◽  
MARIA TRYPAKI ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Messenger Rna ◽  
Small Cell ◽  
Rna Expression ◽  
Advanced Stage ◽  
Small Cell Lung ◽  
Predicting Outcome
Sign in / Sign up

Export Citation Format

Share Document